PineTree Therapeutics
Signal active
Organization
Contact Information
Overview
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
About
Industries
Biotechnology, Medical, Wellness, Therapeutics, Oncology
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
PineTree Therapeutics headquartered in United States, North America, operates in the Biotechnology, Medical, Wellness, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $2.4B in funding across 60 round(s). With a team of 11-50 employees, PineTree Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - PineTree Therapeutics, raised $17.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
7
Lead Investors
0
Total Funding Amount
$40.5M
Details
2
PineTree Therapeutics has raised a total of $40.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 23.5M | ||
| 2024 | Early Stage Venture | 17.0M |
Investors
PineTree Therapeutics is funded by 19 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| SGI Venture Capital | - | FUNDING ROUND - SGI Venture Capital | 17.0M |
| Schmidt | - | FUNDING ROUND - Schmidt | 17.0M |
| PineTree Therapeutics | - | FUNDING ROUND - PineTree Therapeutics | 17.0M |
| Atinum Partners | - | FUNDING ROUND - Atinum Partners | 17.0M |
Recent Activity
There is no recent news or activity for this profile.